Oncosil Research Development from 2010 to 2026

OSL Stock   0.87  0.06  6.45%   
Oncosil Medical Research Development yearly trend continues to be comparatively stable with very little volatility. Research Development will likely drop to about 2.8 M in 2026. From the period from 2010 to 2026, Oncosil Medical Research Development quarterly data regression had r-value of  0.59 and coefficient of variation of  61.31. View All Fundamentals
 
Research Development  
First Reported
2005-12-31
Previous Quarter
1.4 M
Current Value
2.8 M
Quarterly Volatility
890.6 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Oncosil Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncosil Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 30.6 K, Interest Expense of 789 or Selling General Administrative of 9.1 M, as well as many indicators such as . Oncosil financial statements analysis is a perfect complement when working with Oncosil Medical Valuation or Volatility modules.
  
This module can also supplement various Oncosil Medical Technical models . Check out the analysis of Oncosil Medical Correlation against competitors.

Latest Oncosil Medical's Research Development Growth Pattern

Below is the plot of the Research Development of Oncosil Medical over the last few years. It is Oncosil Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Oncosil Medical's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Oncosil Research Development Regression Statistics

Arithmetic Mean2,869,557
Geometric Mean1,931,317
Coefficient Of Variation61.31
Mean Deviation1,351,221
Median2,888,000
Standard Deviation1,759,415
Sample Variance3.1T
Range5.7M
R-Value0.59
Mean Square Error2.2T
R-Squared0.35
Significance0.01
Slope204,762
Total Sum of Squares49.5T

Oncosil Research Development History

20262.8 M
20254.8 M
20244.2 M
2023M
20222.9 M
20212.4 M
20202.9 M

About Oncosil Medical Financial Statements

Oncosil Medical shareholders use historical fundamental indicators, such as Research Development, to determine how well the company is positioned to perform in the future. Although Oncosil Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Oncosil Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Oncosil Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development4.8 M2.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Oncosil Stock Analysis

When running Oncosil Medical's price analysis, check to measure Oncosil Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncosil Medical is operating at the current time. Most of Oncosil Medical's value examination focuses on studying past and present price action to predict the probability of Oncosil Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncosil Medical's price. Additionally, you may evaluate how the addition of Oncosil Medical to your portfolios can decrease your overall portfolio volatility.